Australia's Memphasys sees best day in a month as IVF device passes verification

Memphasys

01/07/2021 02:21

** Shares of Memphasys Ltd  MEM.AX  rise as much as 7.8% to
A$0.069, marking their biggest intraday pct gain since June 2
    ** Medical device maker says all verification tasks
associated with the upgraded Felix Device have successfully
passed the verification process  urn:newsml:reuters.com:*:nGLF7M8435
    ** The Felix device is used for sperm separation in IVF
clinics
    ** Co anticipates initiating commercial sales discussions in
early access markets in the latter part of the quarter ending
Sept. 30
    ** Stock hits highest since June 25; down 36% YTD, as of
last close

 (Reporting by Arundhati Dutta in Bengaluru)
 ((Arundhati.Dutta@thomsonreuters.com;))